CXCL9 and neoplasm: In contrast to Brca2WT tumours (Fig. 1e), we did not observe a further increase in the number of CD3+ or CD8+ T cells upon Cxcl9 overexpression in the Brca2−/− model (Fig. 3f), possibly as a result of a saturation effect by the elevated STING-dependent chemokines, e.g. Cxcl10.